Literature DB >> 26625735

Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China.

Jiangli Di1, Shannon Rutherford, Cordia Chu.   

Abstract

Cervical cancer continues to be a serious public health problem in the developing world, including China. Because of its large population with geographical and socioeconomic inequities, China has a high burden of cervical cancer and important disparities among different regions. In this review, we first present an overview of the cervical cancer incidence and mortality over time, and focus on diversity and disparity in access to care for various subpopulations across geographical regions and socioeconomic strata in China. Then, we describe population-based cervical cancer screening in China, and in particular implementation of the National Cervical Cancer Screening Program in Rural Areas (NACCSPRA) and the challenges that this program faces. These include low screening coverage, shortage of qualified health care personnel and limited funds. To improve prevention of cervical cancer and obtain better cancer outcomes, the Chinese government needs to urgently consider the following key factors: reducing disparities in health care access, collecting accurate and broadly representative data in cancer registries, expanding target population size and increasing allocation of government funding for training of personnel, improving health education for women, enhancing quality control of screening services and improving a system to increase follow up for women with positive results.

Entities:  

Mesh:

Year:  2015        PMID: 26625735     DOI: 10.7314/apjcp.2015.16.17.7401

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  69 in total

1.  Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China.

Authors:  Linhong Liao; Hui Cheng; Fansheng Zeng; Weijie Zhou; Yanqing Ding
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

2.  Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer.

Authors:  Ying-Fang Wang; Hong-Yun Yang; Xiao-Qin Shi; Yue Wang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

3.  Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China.

Authors:  Li Xue; Wenqi Hu; Haiman Zhang; Zhongling Xie; Xi Zhang; Fanghui Zhao; Youlin Qiao; Lijie Gao; Wei Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

4.  MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.

Authors:  Hai-Xia Liang; Yu-Hong Li
Journal:  Genes Genomics       Date:  2020-01-04       Impact factor: 1.839

5.  Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.

Authors:  Fangfang Xu; Jiacheng Shen; Shaohua Xu
Journal:  Front Genet       Date:  2021-05-24       Impact factor: 4.599

6.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

7.  Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.

Authors:  Yanxia Zhao; Heling Bao; Lan Ma; Bo Song; Jiangli Di; Linhong Wang; Yanqiu Gao; Wenhui Ren; Shi Wang; Hai-Jun Wang; Jiuling Wu
Journal:  BMC Med       Date:  2021-07-15       Impact factor: 8.775

8.  Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis.

Authors:  Menghan Guo; Juan Xu; Jiayue Du
Journal:  BMC Public Health       Date:  2021-07-06       Impact factor: 3.295

9.  MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Authors:  Ningmin Zhao; Qing Luo; Ruijuan Lin; Qiaoyan Li; Peizhi Ma
Journal:  Clin Exp Nephrol       Date:  2021-06-18       Impact factor: 2.617

10.  Incidence and mortality of laryngeal cancer in China, 2008-2012.

Authors:  Yuqin Liu; Qin Zhao; Gaoheng Ding; Yitong Zhu; Wenying Li; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.